Ionis Pharmaceuticals, Inc. · NASDAQ:IONS
Schneider Eugene sold 26,000 Ionis Pharmaceuticals, Inc. shares (Form 4)
Traded Jun 26, 2026 · Filed Jun 30, 2026
On Jun 26, 2026, Schneider Eugene (EVP, Chf Clinical Develop Ofcr) sold 26,000 Ionis Pharmaceuticals, Inc. shares at US$81.05 for US$2.11M under a trading plan, leaving 77,114 shares. Filed Jun 30, 2026 (Form 4).
- Sold
- 26,000 shares
- Price
- US$81.05
- Value
- US$2.11M
- Holding after
- 77,114 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- EVP, Chf Clinical Develop Ofcr
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Jun 26, 2026 | Common Stock | Option exercise | 26,000 | US$60.89 | 103,114 | Direct |
| Jun 26, 2026 | Common Stock | Sale | 26,000 | US$81.05 | 77,114 | Direct |